Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11863942
[patent_doc_number] => 20170231228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'SURFACE TREATMENTS'
[patent_app_type] => utility
[patent_app_number] => 15/585296
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10634
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585296
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585296 | SURFACE TREATMENTS | May 2, 2017 | Abandoned |
Array
(
[id] => 14213911
[patent_doc_number] => 20190119340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => PEPTIDES AND NANOPARTICLE FORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/096947
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096947 | PEPTIDES AND NANOPARTICLE FORMULATIONS THEREOF | May 1, 2017 | Abandoned |
Array
(
[id] => 11852060
[patent_doc_number] => 20170226553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'METHODS OF CELL CULTURE'
[patent_app_type] => utility
[patent_app_number] => 15/496368
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20803
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/496368 | Methods of cell culture | Apr 24, 2017 | Issued |
Array
(
[id] => 12185451
[patent_doc_number] => 20180044387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 15/492085
[patent_app_country] => US
[patent_app_date] => 2017-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19906
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15492085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/492085 | SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE | Apr 19, 2017 | Abandoned |
Array
(
[id] => 16640909
[patent_doc_number] => 10918730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Pegylated bioactive peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/094565
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11024
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094565 | Pegylated bioactive peptides and uses thereof | Apr 17, 2017 | Issued |
Array
(
[id] => 16246103
[patent_doc_number] => 10745444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same
[patent_app_type] => utility
[patent_app_number] => 15/488550
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5879
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488550
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488550 | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same | Apr 16, 2017 | Issued |
Array
(
[id] => 16640906
[patent_doc_number] => 10918727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Peptide with ability to penetrate cell membrane
[patent_app_type] => utility
[patent_app_number] => 16/092190
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 32
[patent_no_of_words] => 23682
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092190 | Peptide with ability to penetrate cell membrane | Apr 5, 2017 | Issued |
Array
(
[id] => 14291741
[patent_doc_number] => 10285977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Compositions and methods for treating alopecia
[patent_app_type] => utility
[patent_app_number] => 15/478547
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 7448
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478547
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478547 | Compositions and methods for treating alopecia | Apr 3, 2017 | Issued |
Array
(
[id] => 11992512
[patent_doc_number] => 20170296667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Caspofungin Acetate Formulations'
[patent_app_type] => utility
[patent_app_number] => 15/474531
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8438
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15474531
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/474531 | Caspofungin Acetate Formulations | Mar 29, 2017 | Abandoned |
Array
(
[id] => 12904693
[patent_doc_number] => 20180193406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => PEPTIDE FOR SKIN REGENERATION OR WOUND TREATMENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/739894
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739894
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739894 | Peptide for skin regeneration or wound treatment and use thereof | Mar 20, 2017 | Issued |
Array
(
[id] => 11851662
[patent_doc_number] => 20170226155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'Smart Pro-Drugs of Serine Protease Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/458191
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 108
[patent_figures_cnt] => 108
[patent_no_of_words] => 26514
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458191
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458191 | Smart Pro-Drugs of Serine Protease Inhibitors | Mar 13, 2017 | Abandoned |
Array
(
[id] => 15086479
[patent_doc_number] => 20190338050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => PRODUCTION METHOD FOR NONCYCLIC PEPTIDE-NUCLEIC ACID COMPLEX HAVING, AT N-TERMINAL, AMINO ACID WITH THIOL GROUP NEAR AMINO GROUP, LIBRARY THEREOF, AND CYCLIC PEPTIDE-NUCLEIC ACID COMPLEX LIBRARY DERIVED FROM SAME
[patent_app_type] => utility
[patent_app_number] => 16/081522
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081522 | PRODUCTION METHOD FOR NONCYCLIC PEPTIDE-NUCLEIC ACID COMPLEX HAVING, AT N-TERMINAL, AMINO ACID WITH THIOL GROUP NEAR AMINO GROUP, LIBRARY THEREOF, AND CYCLIC PEPTIDE-NUCLEIC ACID COMPLEX LIBRARY DERIVED FROM SAME | Mar 2, 2017 | Pending |
Array
(
[id] => 13957895
[patent_doc_number] => 20190055291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => FUSION RESPIRATORY SYNCYTIAL VIRUS INHIBITORS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/081431
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081431 | Fusion respiratory syncytial virus inhibitors and use thereof | Mar 1, 2017 | Issued |
Array
(
[id] => 12880783
[patent_doc_number] => 20180185436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => PEPTIDE FOR PREVENTING OR TREATING INFLAMMATORY DISEASES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/739942
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739942 | Peptide for preventing or treating inflammatory diseases and use thereof | Feb 26, 2017 | Issued |
Array
(
[id] => 13354651
[patent_doc_number] => 20180228865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => PEPTIDE FOR PREVENTING OR TREATING INFLAMMATORY DISEASES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/739953
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739953
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739953 | Peptide for preventing or treating inflammatory diseases and use thereof | Feb 26, 2017 | Issued |
Array
(
[id] => 11971188
[patent_doc_number] => 20170275342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/440730
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20808
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440730 | PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS | Feb 22, 2017 | Abandoned |
Array
(
[id] => 14196385
[patent_doc_number] => 10265278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Pharmaceutical compositions and methods utilizing a D-amino acid
[patent_app_type] => utility
[patent_app_number] => 15/436901
[patent_app_country] => US
[patent_app_date] => 2017-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5088
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436901 | Pharmaceutical compositions and methods utilizing a D-amino acid | Feb 19, 2017 | Issued |
Array
(
[id] => 11942094
[patent_doc_number] => 20170246244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'Charged Nutritive Proteins and Methods'
[patent_app_type] => utility
[patent_app_number] => 15/429420
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 50908
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429420 | Charged nutritive proteins and methods | Feb 9, 2017 | Issued |
Array
(
[id] => 12057177
[patent_doc_number] => 20170333521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHOD FOR TARGETED INTRAPROSTATIC ADMINISTRATION OF PRX302 FOR TREATMENT OF PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/418571
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4594
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15418571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/418571 | METHOD FOR TARGETED INTRAPROSTATIC ADMINISTRATION OF PRX302 FOR TREATMENT OF PROSTATE CANCER | Jan 26, 2017 | Abandoned |
Array
(
[id] => 11602560
[patent_doc_number] => 20170119860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE'
[patent_app_type] => utility
[patent_app_number] => 15/403886
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22200
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15403886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/403886 | ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE | Jan 10, 2017 | Abandoned |